1
REPORTAGE - IGS GEBOJAGEMA
Three shifts – only one manned Focusing on a demanding market, consistent automation and intensified digitalization: this is the recipe for success, which is behind the impressive growth of the Dutch company IGS GeboJagema. EROWA has been on board as a partner for more than 30 years, starting with the ITS Tooling system. The market It is well-known that tool- and mold-making is a fiercely contested market. IGS GeboJagema concentrates on the three focal areas of healthcare, optics and medical packaging. “In these markets, we successfully operate as full service providers,” says Hans Arts, the company’s Sales Director. “We offer considerable engineering power with a lot of experience as well as insourcing with innovative tool design and solutions.” The products range from small injection molds with low cavitation to complex multi-cavity injection molds. In 2018, the company produced a total of more than 300 molds with a total of 96 employees. “Although the medical market is extremely demanding and quality-oriented, it’s less sensitive to prices,” explains Hans Arts. “In addition, our pharmaceutical customers’ development costs and processes are sometimes very long, which means that in the long term, great value is attached to the relationship between customer and toolmaker. And we benefit from this.”
USPs There are three additional features, which ensured IGS GeboJagema’s good position in the market, says Hans Arts: “One thing is the fact that Industry 4.0 is living practice with us. Besides EROWA’s workpiece clamping systems, which ensure the flexible and precise use of the workpiece carriers throughout the manufacturing process, the JMS 4.0 is now one of the pillars of our operation. Also, we work completely paperless. And last but not least; our in-house engineering experience for innovative mold design and solutions gives us the edge over many competitors.” “In addition, we’re proud of our great deal of know-how and many years of experience in strict tool validation,” Hans Arts continues. “We check and test and ensure that the injectionmolding tool that we’ve produced does indeed fulfil the task for which it is intended. Whatever leaves our production line can be put to use at once. This resulting in positioning IGS GeboJagema as top tool supplier to healthcare OEMs”. Automation IGS GeboJagema also opted for automation at an early stage. „This is the merit of our CEO, Peter Mertens“, explains Hans Arts. „He realized early on that the only possibility for us to remain competitive in our market was to offer high-quality, high-precision molds, produced in the most efficient way